ArticleDiscover oncology2024
Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment.
Bavya Chandrasekhar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleDiscover oncology2024
Bavya Chandrasekhar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.